Results 101 to 110 of about 5,715 (232)

High‐Precision Hemodynamic and Echocardiographic Assessment of Pacing in Obstructive Hypertrophic Cardiomyopathy

Pacing and Clinical Electrophysiology, Volume 48, Issue 10, Page 1138-1147, October 2025.
In obstructive hypertrophic cardiomyopathy (oHCM), right ventricular pacing (RVP) can desynchronize the left ventricle to relieve outflow tract obstruction and allow control of atrioventricular delay (AVD), but may impair ventricular function. In twenty two patients with oHCM, a high‐precision RVP protocol quantified outflow tract gradient (LVOTg) and ...
Jagdeep S. Mohal, Matthew J. Shun‐Shin, Kayla Chiew, Alejandra A. Miyazawa, Florentina Simader, Pannathorn Tangkongpanich, Rahul Bahl, Ji‐Jian Chow, James P. Howard, Akriti Naraen, Keenan Saleh, Jack W. Samways, Daniel Keene, S. M. Afzal Sohaib, Mark Tanner, Kevin M. W. Leong, Norman A. Qureshi, David C. Lefroy, Prapa Kanagaratnam, Darrel P. Francis, Amanda Varnava, Zachary I. Whinnett, Ahran D. Arnold   +22 more
wiley   +1 more source

Endocardial septal ablation for hypertrophic obstructive cardiomyopathy

Türk Kardiyoloji Derneği Arşivi, 2017
Summary– Septal reduction therapy (SRT) is the accepted therapeutic option for symptomatic hypertrophic obstructive cardiomyopathy (HOCM). At this time, surgical septal myectomy is the gold standard method, but alcohol septal ablation is an acceptable ...
Tolga Aksu, Tümer Erdem Güler, Kıvanç Yalın, Şükriye Ebru Gölcük, Kazım Serhan Özcan   +4 more
doaj   +1 more source

Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy

Cardiovascular Ultrasound, 2022
Background Perfusion defects during stress can occur in hypertrophic cardiomyopathy (HCM) from either structural or functional abnormalities of the coronary microcirculation.
Paola Roldan, Sriram Ravi, James Hodovan, J. Todd Belcik, Stephen B. Heitner, Ahmad Masri, Jonathan R. Lindner   +6 more
doaj   +1 more source

Significance of left ventricular apical-basal muscle bundle identified by cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy [PDF]

, 2017
Aims Cardiovascular magnetic resonance (CMR) has improved diagnostic and management strategies in hypertrophic cardiomyopathy (HCM) by expanding our appreciation for the diverse phenotypic expression. We sought to characterize the prevalence and clinical
Appelbaum, Evan, Care, Melanie, Chan, Raymond H., Crean, Andrew, Deva, Djeven, Gibson, C. Michael, Gruner, Christiane, Haas, Tammy S., Lesser, John R., Manning, Warren J., Maron, Barry J., Maron, Martin S., Rakowski, Harry, Ralph-Edwards, Anthony C., Rastegar, Hassan, Rowin, Ethan J., Siminovitch, Katherine, Udelson, James E., Williams, Lynne   +18 more
core  

A next-generation sequencing approach to identify gene mutations in early-and late-onset hypertrophic cardiomyopathy patients of an Italian cohort [PDF]

, 2016
Sequencing of sarcomere protein genes in patients fulfilling the clinical diagnostic criteria for hypertrophic cardiomyopathy (HCM) identifies a disease-causing mutation in 35% to 60% of cases.
Autore, Camillo, Bozzao, Cristina, Chessa, Luciana, Francia, Pietro, Germani, Aldo, Musumeci, Maria Beatrice, Pagannone, Erika, Pennacchini, Ermelinda, Piane, Maria, Rubattu, Speranza, Savio, Camilla, Volpe, Massimo   +11 more
core   +1 more source

Commentary: Cox maze with septal myectomy [PDF]

The Journal of Thoracic and Cardiovascular Surgery, 2021
Harold G, Roberts, Lawrence M, Wei, Vinay, Badhwar   +2 more
openaire   +2 more sources

Mitochondrial targets in ischaemic heart disease and heart failure, and their potential for a more efficient clinical translation. A scientific statement of the ESC Working Group on Cellular Biology of the Heart and the ESC Working Group on Myocardial Function

European Journal of Heart Failure, Volume 27, Issue 9, Page 1720-1736, September 2025.
Improving clinical translation of mitoprotective therapies. 31P MRI, phosphorus‐31 magnetic resonance imaging; hiPSC‐CM, human‐induced pluripotent stem cell‐derived cardiomyocyte; IHD, ischaemic heart disease. Abstract Acute myocardial infarction (MI) remains a major cause of death and disability worldwide.
Melanie Paillard, Mahmoud Abdellatif, Ioanna Andreadou, Christian Bär, Luc Bertrand, Bianca J.J.M. Brundel, Gemma Chiva‐Blanch, Sean M. Davidson, Dana Dawson, Fabio Di Lisa, Paul Evans, Zoltan Giricz, Derek J. Hausenloy, Petra Kleinbongard, Frank Lezoualc'h, Elisa Liehn, Christoph Maack, Ange Maguy, Elizabeth Murphy, Cinzia Perrino, Maurizio Pesce, Peter P. Rainer, Katrin Streckfuss‐Bömeke, Matthias Thielmann, Rong Tian, Carlo G. Tocchetti, Jolanda Van Der Velden, Sophie Van Linthout, Serena Zacchigna, Thomas Krieg   +29 more
wiley   +1 more source

Risk factors for reoperation after relief of congenital subaortic stenosis [PDF]

, 2017
Background: Congenital subaortic stenosis entails a lesion spectrum, ranging from an isolated obstructive membrane, to complex tunnel narrowing of the left outflow associated with other cardiac defects.
Bauersfeld, Urs, Dodge-Khatami, Ali, Doell, Carsten, Fasnacht, Margrit, Prêtre, René, Rousson, Valentin, Schmid, Michael   +6 more
core  

Red blood cell distribution width is associated with adverse cardiovascular events after septal myectomy [PDF]

, 2021
Shuiyun Wang, Changpeng Song, Hao Cui, Changsheng Zhu, Rong Wu, Xiaohong Huang, Yongqiang Lai, Shuiyun Wang   +7 more
openalex   +1 more source

A Road Less Traveled: Successful Alcohol Septal Ablation via an Aberrant Septal Coronary Artery in Hypertrophic Obstructive Cardiomyopathy

Catheterization and Cardiovascular Interventions, Volume 106, Issue 2, Page 1273-1279, August 1, 2025.
ABSTRACT Alcohol septal ablation (ASA) is a minimally invasive treatment option for patients with hypertrophic obstructive cardiomyopathy (HOCM) who remain symptomatic despite medical treatment and are either poor surgical candidates or prefer a less invasive approach.
Vishnu Bharani, Vishal I. Patel, Morton J. Kern, Pranav M. Patel   +3 more
wiley   +1 more source